Home / Drug shortages / Tranylcypromine Sulfate Tablet

Tranylcypromine Sulfate Tablet — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Tranylcypromine Sulfate Tablet (tablet) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on 10/21/2025.

Shortage Details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0591-5590-01
Dosage Form
Tablet
Presentation
Parnate, Tablet, 10 mg (NDC 0591-5590-01)
Initial Posting
10/21/2025
Revised Date

FDA data resources